Coreg Related Published Studies
Well-designed clinical trials related to Coreg (Carvedilol)
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. [2009.09]
Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial. [2009.08]
Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial. [2009.06]
The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure. [2009]
Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. [2008.09]
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study. [2008.09]
Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy. [2008.06]
Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. [2008.05.07]
Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. [2008.04]
Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study. [2008.04]
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. [2008.03]
The impact of carvedilol on the defibrillation threshold. [2008.01]
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure. [2007.12]
Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. [2007.11.08]
Carvedilol in dogs with dilated cardiomyopathy. [2007.11]
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure. [2007.11]
Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN). [2007.10]
Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol. [2007.10]
Carvedilol for children and adolescents with heart failure: a randomized controlled trial. [2007.09.12]
Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. [2007.09]
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET). [2007.08]
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial. [2007.08]
Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant? [2007.08]
Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction. [2007.07]
Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. [2007.07]
Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. [2007.06]
Achiral-chiral LC/LC-FLD coupling for determination of carvedilol in plasma samples for bioequivalence purposes. [2007.05.01]
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. [2007.04]
Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. [2007.04]
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. [2007.03.06]
Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction. [2007.02]
Effects of Long-term Treatment with Carvedilol on Myocardial Blood Flow in Idiopathic Dilated Cardiomyopathy. [2007.01.19]
Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial. [2007]
Protective effects of carvedilol against anthracycline-induced cardiomyopathy. [2006.12.05]
Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension. [2006.12]
Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers. [2006.12]
Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial). [2006.11.10]
Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia. [2006.11]
[The effectiveness of carvedilol in heart failure] [2006.10.08]
Controlled-release carvedilol in the treatment of essential hypertension. [2006.10.02]
Randomized, double-blind comparison of acute beta1-blockade with 50 mg metoprolol tartrate vs 25 mg carvedilol in normal subjects. [2006.09]
Carvedilol versus Metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: rationale and design of the Carvedilol or Metoprolol Post-Revascularization Atrial Fibrillation Controlled Trial (COMPACT). [2006.06]
Comparing Beta-Blocking Effects of Bisoprolol, Carvedilol and Nebivolol. [2006.05.04]
The effect of carvedilol on metabolic parameters in patients with metabolic syndrome. [2006.05]
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET). [2006.04.18]
Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits. [2006.04]
After myocardial infarction carvedilol improves insulin resistance compared to metoprolol. [2006.02]
The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis. [2006.02]
Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients. [2006.01.15]
Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention--the PASSAT Study. [2006.01]
Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. [2006]
Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. [2006]
Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. [2005.12]
Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study. [2005.12]
Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study. [2005.11]
Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure. [2005.11]
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. [2005.11]
Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure. [2005.10]
Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization. [2005.09]
Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to bioequivalence study. [2005.08.05]
Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure. [2005.08]
Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure. [2005.06]
Carvedilol reduces plasma 8-hydroxy-2'-deoxyguanosine in mild to moderate hypertension: a pilot study. [2005.05]
A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. [2005.03.15]
Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial. [2005.03]
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial. [2005.03]
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. [2005.02.15]
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET. [2005.02]
Carvedilol versus metoprolol in the acute phase of myocardial infarction:. [2005.01]
Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers. [2005]
A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients. [2005]
Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy. [2004.12.01]
Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients. [2004.12]
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. [2004.11.10]
Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. [2004.11.02]
Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis. [2004.10]
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. [2004.09.28]
Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation. [2004.09.01]
Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction. [2004.08.15]
Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET. [2004.07]
Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study. [2004.07]
Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo. [2004.06.29]
Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN). [2004.06]
Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure. [2004.06]
Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). [2004.06]
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure. [2004.05.06]
Tolerability of carvedilol in heart failure: clinical trials experience. [2004.05.06]
Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure. [2004.05.06]
Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program. [2004.05.06]
Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN). [2004.05.06]
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. [2004.05.05]
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. [2004.04.21]
Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. [2004.04.01]
Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers. [2004.04]
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET). [2004.03]
Comparison between a sustained administration of carvedilol versus atenolol to reduce restenosis after coronary stenting. [2004.02]
Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. [2004.02]
Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. [2004.01.20]
The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). [2004.01]
Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure. [2004.01]
Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison. [2004]
|
